 Nonketotic hyperglycinemia treatment NMDA antagonist consideration neuropathogenesis Patients neonatal-onset nonketotic hyperglycinemia high-glycine content cerebrospinal fluid CSF cause intractable neurologic manifestations glycine receptor inhibitory central nervous system glycine receptor excitatory N-methyl-D-aspartate NMDA receptor type strychnine NMDA receptor antagonist ketamine patient nonketotic hyperglycinemia improvement hyperirritability voluntary movement electroencephalographic findings Strychnine therapy trial NMDA antagonist improvement respiratory condition reduction CSF glycine level withdrawal sodium valproate findings high-glycine content CSF brain different ways NMDA classic glycine receptors